Drug
Nnc0194 0499
Nnc0194 0499: highest development phase Phase 1, developed by Novo Nordisk. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Novo Nordisk
Trials
| Drug | Phase | Indication |
|---|---|---|
| NNC0194-0499 NCT03015207 | Phase 1 | Metabolism and Nutrition Disorder |
Latest
No recent events.
Follow Nnc0194 0499 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.